Search

Author/Creator Wakefield, Amanda

1. A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma. (4th November 2015)

Authors:
Hegde, Meenakshi; Grada, Zakaria; Pignata, Antonella; Wakefield, Amanda; Fousek, Kristen; Bielamowicz, Kevin; Chow, Kevin; Brawley, Vita; Byrd, Tiara; Gottschalk, Stephen; Mukherjee, Malini; Wels, Winfried S; Baker, Matthew; Dotti, Giapietro; Orange, Jordan; Ahmed, Nabil
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma. Issue 2 (December 2015)

Authors:
Hegde, Meenakshi; Grada, Zakaria; Pignata, Antonella; Wakefield, Amanda; Fousek, Kristen; Bielamowicz, Kevin; Chow, Kevin; Brawley, Vita; Byrd, Tiara; Gottschalk, Stephen; Mukherjee, Malini; Wels, Winfried; Baker, Matthew; Dotti, Giapietro; Orange, Jordan; Ahmed, Nabil
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. (4th November 2015)

Authors:
Ahmed, Nabil; Brawley, Vita; Hegde, Meenakshi; Bielamowicz, Kevin; Wakefield, Amanda; Ghazi, Alexia; Ashoori, Aidin; Diouf, Oumar; Gerken, Claudia; Landi, Daniel; Kalra, Mamta; Yi, Zhongzhen; Rooney, Cliona; Dotti, Gianpietro; Gee, Adrian; Heslop, Helen; Gottschalk, Stephen; Powell, Suzanne; Gros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. Issue 2 (December 2015)

Authors:
Ahmed, Nabil; Brawley, Vita; Hegde, Meenakshi; Bielamowicz, Kevin; Wakefield, Amanda; Ghazi, Alexia; Ashoori, Aidin; Diouf, Oumar; Gerken, Claudia; Landi, Daniel; Kalra, Mamta; Yi, Zhongzhen; Rooney, Cliona; Dotti, Gianpietro; Gee, Adrian; Heslop, Helen; Gottschalk, Stephen; Powell, Suzanne; Gros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Dual targeting of the tumor and its associated vasculature using a single bispecific chimeric antigen receptor molecule. (6th November 2014)

Authors:
Byrd, Tiara; Fousek, Kristen; Pignata, Antonella; Wakefield, Amanda; Grada, Zakaria; Aviles-Padilla, Kevin; Fletcher, Bradley S; Hegde, Meenakshi; St Croix, Brad; Ahmed, Nabil
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗